226 related articles for article (PubMed ID: 11517410)
1. JCV-specific cellular immune response correlates with a favorable clinical outcome in HIV-infected individuals with progressive multifocal leukoencephalopathy.
Du Pasquier RA; Clark KW; Smith PS; Joseph JT; Mazullo JM; De Girolami U; Letvin NL; Koralnik IJ
J Neurovirol; 2001 Aug; 7(4):318-22. PubMed ID: 11517410
[TBL] [Abstract][Full Text] [Related]
2. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.
Du Pasquier RA; Kuroda MJ; Zheng Y; Jean-Jacques J; Letvin NL; Koralnik IJ
Brain; 2004 Sep; 127(Pt 9):1970-8. PubMed ID: 15215217
[TBL] [Abstract][Full Text] [Related]
3. JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy.
Koralnik IJ; Du Pasquier RA; Letvin NL
J Virol; 2001 Apr; 75(7):3483-7. PubMed ID: 11238876
[TBL] [Abstract][Full Text] [Related]
4. Determinants of survival in progressive multifocal leukoencephalopathy.
Marzocchetti A; Tompkins T; Clifford DB; Gandhi RT; Kesari S; Berger JR; Simpson DM; Prosperi M; De Luca A; Koralnik IJ
Neurology; 2009 Nov; 73(19):1551-8. PubMed ID: 19901246
[TBL] [Abstract][Full Text] [Related]
5. Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope.
Koralnik IJ; Du Pasquier RA; Kuroda MJ; Schmitz JE; Dang X; Zheng Y; Lifton M; Letvin NL
J Immunol; 2002 Jan; 168(1):499-504. PubMed ID: 11751998
[TBL] [Abstract][Full Text] [Related]
6. Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathy.
Du Pasquier RA; Kuroda MJ; Schmitz JE; Zheng Y; Martin K; Peyerl FW; Lifton M; Gorgone D; Autissier P; Letvin NL; Koralnik IJ
J Virol; 2003 Nov; 77(22):11918-26. PubMed ID: 14581528
[TBL] [Abstract][Full Text] [Related]
7. Overview of the cellular immunity against JC virus in progressive multifocal leukoencephalopathy.
Koralnik IJ
J Neurovirol; 2002 Dec; 8 Suppl 2():59-65. PubMed ID: 12491153
[TBL] [Abstract][Full Text] [Related]
8. Presence of JC virus-specific CTL in the cerebrospinal fluid of PML patients: rationale for immune-based therapeutic strategies.
Du Pasquier RA; Autissier P; Zheng Y; Jean-Jacques J; Koralnik IJ
AIDS; 2005 Dec; 19(18):2069-76. PubMed ID: 16284455
[TBL] [Abstract][Full Text] [Related]
9. Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy.
Lima MA; Marzocchetti A; Autissier P; Tompkins T; Chen Y; Gordon J; Clifford DB; Gandhi RT; Venna N; Berger JR; Koralnik IJ
J Virol; 2007 Apr; 81(7):3361-8. PubMed ID: 17229701
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcome of long-term survivors of progressive multifocal leukoencephalopathy.
Lima MA; Bernal-Cano F; Clifford DB; Gandhi RT; Koralnik IJ
J Neurol Neurosurg Psychiatry; 2010 Nov; 81(11):1288-91. PubMed ID: 20710013
[TBL] [Abstract][Full Text] [Related]
11. Brief Report: Decreased JC Virus-Specific Antibody-Dependent Cellular Cytotoxicity in HIV-Seropositive PML Survivors.
Tan CS; Ghofrani J; Geiger E; Koralnik IJ; Jost S
J Acquir Immune Defic Syndr; 2019 Oct; 82(2):220-224. PubMed ID: 31513076
[TBL] [Abstract][Full Text] [Related]
12. Human polyomavirus JC latency and reactivation status in blood of HIV-1-positive immunocompromised patients with and without progressive multifocal leukoencephalopathy.
Andréoletti L; Dubois V; Lescieux A; Dewilde A; Bocket L; Fleury HJ; Wattré P
AIDS; 1999 Aug; 13(12):1469-75. PubMed ID: 10465069
[TBL] [Abstract][Full Text] [Related]
13. Changes in JC virus-specific T cell responses during natalizumab treatment and in natalizumab-associated progressive multifocal leukoencephalopathy.
Perkins MR; Ryschkewitsch C; Liebner JC; Monaco MC; Himelfarb D; Ireland S; Roque A; Edward HL; Jensen PN; Remington G; Abraham T; Abraham J; Greenberg B; Kaufman C; LaGanke C; Monson NL; Xu X; Frohman E; Major EO; Douek DC
PLoS Pathog; 2012; 8(11):e1003014. PubMed ID: 23144619
[TBL] [Abstract][Full Text] [Related]
14. Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy.
Gasnault J; Kahraman M; de Goër de Herve MG; Durali D; Delfraissy JF; Taoufik Y
AIDS; 2003 Jul; 17(10):1443-9. PubMed ID: 12824781
[TBL] [Abstract][Full Text] [Related]
15. JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy.
Khanna N; Wolbers M; Mueller NJ; Garzoni C; Du Pasquier RA; Fux CA; Vernazza P; Bernasconi E; Viscidi R; Battegay M; Hirsch HH;
J Virol; 2009 May; 83(9):4404-11. PubMed ID: 19211737
[TBL] [Abstract][Full Text] [Related]
16. Efficient in vitro expansion of JC virus-specific CD8(+) T-cell responses by JCV peptide-stimulated dendritic cells from patients with progressive multifocal leukoencephalopathy.
Marzocchetti A; Lima M; Tompkins T; Kavanagh DG; Gandhi RT; O'Neill DW; Bhardwaj N; Koralnik IJ
Virology; 2009 Jan; 383(2):173-7. PubMed ID: 19062062
[TBL] [Abstract][Full Text] [Related]
17. Semiquantitative detection of JCV-DNA in peripheral blood leukocytes from HIV-1-infected patients with or without progressive multifocal leukoencephalopathy.
Andréoletti L; Lescieux A; Lambert V; Si-Mohamed A; Matta M; Wattré P; Bélec L
J Med Virol; 2002 Jan; 66(1):1-7. PubMed ID: 11748651
[TBL] [Abstract][Full Text] [Related]
18. Cellular and humoral immune response in progressive multifocal leukoencephalopathy.
Weber F; Goldmann C; Krämer M; Kaup FJ; Pickhardt M; Young P; Petry H; Weber T; Lüke W
Ann Neurol; 2001 May; 49(5):636-42. PubMed ID: 11357954
[TBL] [Abstract][Full Text] [Related]
19. Analysis of JC virus genotype distribution and transcriptional control region rearrangements in human immunodeficiency virus-positive progressive multifocal leukoencephalopathy patients with and without highly active antiretroviral treatment.
Ferrante P; Delbue S; Pagani E; Mancuso R; Marzocchetti A; Borghi E; Maserati R; Bestetti A; Cinque P
J Neurovirol; 2003; 9 Suppl 1():42-6. PubMed ID: 12709871
[TBL] [Abstract][Full Text] [Related]
20. Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient.
Balduzzi A; Lucchini G; Hirsch HH; Basso S; Cioni M; Rovelli A; Zincone A; Grimaldi M; Corti P; Bonanomi S; Biondi A; Locatelli F; Biagi E; Comoli P
Bone Marrow Transplant; 2011 Jul; 46(7):987-92. PubMed ID: 20921942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
